Subscribe to Newsletter

Harry Quigley

The Power List 2014

Harry Quigley

A founding member of the American Glaucoma Society, former CEO of ARVO and former Editor-in-Chief IOVS, Harry Quigley’s research has enabled earlier glaucoma diagnosis and described the degree of optical nerve damage that had occurred before glaucoma is typically detected. His current research interests include gene and stem cell therapies.

Part of the Power List 2014

The 100 most influential people

Who are the 100 most influential people in ophthalmology?
That’s the question we posed to ourselves – and then to you – over two months ago, ahead of open nominations and a painstaking judging process. Here, without further ado, we celebrate the answer.

Go to The Power List 2014

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine



The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: